|
Gender (%) | Male 38 (84%) Female 7 (16%) |
|
Cause of Liver Disease | |
HBV | 18 |
HCV | 19 |
ETOH | 5 |
Hemochrmatosis | 1 |
|
Age at Diagnosis | 62.8 years |
|
Average Survival after HCC Diagnosis | 28 months |
|
Average Survival after PVT Diagnosis | 15 months |
|
Total Patient 45 Anticoagulation No Yes Initial PVT Involvement Right PVT 18 (40%) Left PVT 13 (28%) Main PVT 6 (13%) Multi Involvement 8 (17%) | PVT Progression 23 19 (49%) 4 (67%) 12 (67%) 7 (54%) 4 (67%) |
|
HCC type | |
Single Lesion | 30 (67%) |
Multifocal | 15 (33%) |
|
HCC Treatment Modality | |
TACE | 19 (42%) |
RFA | 3 (7%) |
TACE + RFA | 8 (18%) |
Systemic Treatment | 35 (78%) |
|
MELD Score (average) | 8.25 |
|
Child | A (71%), B (29%) |
|